Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CD38-NAD+-Sirt1 axis in T cell immunotherapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CD38-NAD+-Sirt1 axis in T cell immunotherapy.
CD38-NAD+-Sirt1 axis in T cell immunotherapy. Aging (Albany NY). 2019 10 23; 11(20):8743-8744.
View in:
PubMed
subject areas
ADP-ribosyl Cyclase 1
Cellular Reprogramming
Gene Expression Regulation, Neoplastic
Genetic Engineering
Histones
Humans
Immunotherapy
Membrane Glycoproteins
Mitochondria
NAD
Neoplasms
Sirtuin 1
T-Lymphocytes
Tumor Microenvironment
authors with profiles
Shikhar Mehrotra
Paramita Chakraborty